問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
張宏
下載
2020-10-26 - 2028-06-30
Condition/Disease
Test Drug
Participate Sites8Sites
Not yet recruiting3Sites
Recruiting5Sites
2025-10-01 - 2029-06-30
Participate Sites6Sites
Recruiting6Sites
2019-05-31 - 2026-12-31
Participate Sites3Sites
Recruiting3Sites
2025-01-03 - 2028-12-31
2018-01-15 - 2029-06-30
Participate Sites7Sites
2020-01-01 - 2027-07-31
Participate Sites5Sites
2021-12-01 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2022-02-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2023-07-01 - 2031-10-30
2020-02-01 - 2023-12-15
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
ION-682884 Injection; Inotersen (ISIS 420915) Injection
全部
